264 related articles for article (PubMed ID: 23938874)
1. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine).
Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S
Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterisation and antibacterial activity of [(p-cym)RuX(L)](+/2+) (X = Cl, H2O; L = bpmo, bpms) complexes.
Tripathy SK; Taviti AC; Dehury N; Sahoo A; Pal S; Beuria TK; Patra S
Dalton Trans; 2015 Mar; 44(11):5114-24. PubMed ID: 25675378
[TBL] [Abstract][Full Text] [Related]
3. Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.
Tripathy SK; De U; Dehury N; Pal S; Kim HS; Patra S
Dalton Trans; 2014 Oct; 43(39):14546-9. PubMed ID: 25160655
[TBL] [Abstract][Full Text] [Related]
4. Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.
Demoro B; de Almeida RF; Marques F; Matos CP; Otero L; Costa Pessoa J; Santos I; Rodríguez A; Moreno V; Lorenzo J; Gambino D; Tomaz AI
Dalton Trans; 2013 May; 42(19):7131-46. PubMed ID: 23519281
[TBL] [Abstract][Full Text] [Related]
5. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic behaviour and chloride ion binding capability of [Ru(η6-p-cym)(H2O)3]2+: a solution equilibrium study.
Bíró L; Farkas E; Buglyó P
Dalton Trans; 2012 Jan; 41(1):285-91. PubMed ID: 22051630
[TBL] [Abstract][Full Text] [Related]
7. Combining [arene-Ru] with azocarboxamide to generate a complex with cytotoxic properties.
Sommer MG; Kureljak P; Urankar D; Schweinfurth D; Stojanović N; Bubrin M; Gazvoda M; Osmak M; Sarkar B; Košmrlj J
Chemistry; 2014 Dec; 20(52):17296-9. PubMed ID: 25376425
[TBL] [Abstract][Full Text] [Related]
8. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands.
Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V
J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and anticancer activity of ruthenium-pyrazole complexes.
David S; Perkins RS; Fronczek FR; Kasiri S; Mandal SS; Srivastava RS
J Inorg Biochem; 2012 Jun; 111():33-9. PubMed ID: 22484498
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structure, and reactivity of new tetranuclear Ru-Hbpp-based water-oxidation catalysts.
Francàs L; Sala X; Escudero-Adán E; Benet-Buchholz J; Escriche L; Llobet A
Inorg Chem; 2011 Apr; 50(7):2771-81. PubMed ID: 21366245
[TBL] [Abstract][Full Text] [Related]
12. New RuII (arene) complexes with halogen-substituted bis- and tris(pyrazol-1-yl)borate ligands.
Orbisaglia S; Di Nicola C; Marchetti F; Pettinari C; Pettinari R; Martins LM; Alegria EC; da Silva MF; Rocha BG; Kuznetsov ML; Pombeiro AJ; Skelton BW; Sobolev AN; White AH
Chemistry; 2014 Mar; 20(13):3689-704. PubMed ID: 24616192
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer.
Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D
Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112
[TBL] [Abstract][Full Text] [Related]
14. Lipophilicity-dependent ruthenium N-heterocyclic carbene complexes as potential anticancer agents.
Lv G; Guo L; Qiu L; Yang H; Wang T; Liu H; Lin J
Dalton Trans; 2015 Apr; 44(16):7324-31. PubMed ID: 25797411
[TBL] [Abstract][Full Text] [Related]
15. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
[TBL] [Abstract][Full Text] [Related]
16. One-pot synthesis of symmetric and asymmetric p-quinone ligands and unprecedented substituent induced reactivity in their dinuclear ruthenium complexes.
Schweinfurth D; Das HS; Weisser F; Bubrin D; Sarkar B
Inorg Chem; 2011 Feb; 50(3):1150-9. PubMed ID: 21214266
[TBL] [Abstract][Full Text] [Related]
17. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
[TBL] [Abstract][Full Text] [Related]
18. Piano-Stool Ruthenium(II) Complexes with Delayed Cytotoxic Activity: Origin of the Lag Time.
Rafols L; Josa D; Aguilà D; Barrios LA; Roubeau O; Cirera J; Soto-Cerrato V; Pérez-Tomás R; Martínez M; Grabulosa A; Gamez P
Inorg Chem; 2021 Jun; 60(11):7974-7990. PubMed ID: 33979132
[TBL] [Abstract][Full Text] [Related]
19. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
20. Bipyrimidine ruthenium(II) arene complexes: structure, reactivity and cytotoxicity.
Betanzos-Lara S; Novakova O; Deeth RJ; Pizarro AM; Clarkson GJ; Liskova B; Brabec V; Sadler PJ; Habtemariam A
J Biol Inorg Chem; 2012 Oct; 17(7):1033-51. PubMed ID: 22791215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
